Novo Nordisk A/S (NYSE:NVO) is considered one of the cheap stocks that will go to the moon according to Reddit. On August 13, BNP Paribas Exane upgraded NVO to Neutral from Underperform with a $54 price target. The company announced an operating profit growth of 25% in Danish kroner and 29% at constant exchange rates to DKK 72.2 billion for the January 1 to June 30 period. Sales in US Operations rose by 16% in Danish kroner, while International Operations saw a 16% increase in Danish kroner. Novo Nordisk A/S specializes in diabetes care and pharmaceutical products, with operations in biopharmaceuticals and diabetes and obesity care.

Read more at Yahoo Finance: BNP Paribas Exane Upgrades Novo Nordisk (NVO) to Neutral from Underperform